Objectives: Although the United States has safe haven laws, which allow mothers to safely relinquish their babies to designated safety points, rates of infant mortality remain significantly higher in the United States than other similarly developed countries. The current study is seeking to explore the state-level impact of safe haven laws on infant mortality in the United States utilizing a legal epidemiological approach. Methods: Several sources of publicly available data were combined to examine the state-level impact of safe haven laws on rates of infant mortality. A backward stepwise regression was used to determine whether certain safe haven laws significantly predicted rates of infant mortality, while controlling for demographic variables. Results: After controlling for demographic variables including race, poverty, and education, safe haven laws regarding who is permitted to relinquish a child significantly predicted rates of infant mortality, with the total model accounting for 74.4% of variance in infant mortality. Conclusion: Safe haven laws pertaining to who may relinquish infants significantly predicted infant mortality, specifically laws stating only the mother may relinquish the child and laws which do not specify who may relinquish the child. These results have important implications for policymakers considering the reform of the safe haven laws. It is especially important to evaluate the effectiveness and origins of safe haven laws in the wake of the overturn of Roe v. Wade. Future studies should longitudinally examine how changes in safe haven laws lead to changes in rates of infant mortality.  

The authors have declared no competing interest.

This study did not receive funding.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced are available online.